Férid Haddad (Ferid Haddad)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Aqueous Solution

Multiple Myeloma

Top Venues

International journal of molecular sciences

GIP Arronax

Université de Nantes (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GIP Arronax Jul 1o 2014

France

Director

Education History

Université de Nantes Sep 1o 1991 - Oct 29o 1993

France

PHD :: Physics

Publications

Cassandra Métivier, Patricia Le Saëc, Joëlle Gaschet, Catherine Chauvet, Séverine Marionneau-Lambot, Peter O Hofgaard, Bjarne Bogen, Julie Pineau, Nathalie Le Bris, Pr Raphael Tripier, Cyrille Alliot, Férid Haddad, Michel Cherel, Nicolas Chouin, Alain Faivre-Chauvet, Latifa Rbah-Vidal
Preclinical Evaluation of a 64 Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma. Pharmaceutics 15 (7) (2023)
Arthur Bongrand, Charbel Koumeir, Daphnée Villoing, Arnaud Guertin, Férid Haddad, Vincent Métivier, Freddy Poirier, Vincent Potiron, Noël Servagent, Stéphane Supiot, Grégory Delpon, Sophie Chiavassa
A Monte Carlo Determination of Dose and Range Uncertainties for Preclinical Studies with a Proton Beam. Cancers 13 (8) (2021)
Romain Eychenne, Michel Cherel, Férid Haddad, François Guérard, Jean-François Gestin
Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The "Hopeful Eight". Pharmaceutics 13 (6) (2021)
Clement Bailly, Sébastien Gouard, François Guérard, Benjamin Chalopin, Thomas Carlier, Alain Faivre-Chauvet, Patricia Remaud-Le Saëc, Mickaël Bourgeois, Nicolas Chouin, Latifa Rbah-Vidal, Pr Raphael Tripier, Férid Haddad, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, Michel Chérel
What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model. International journal of molecular sciences 20 (10) (2019)